Corthera Garners New Funding

  • Feed Type
  • Date
    12/31/2008
  • Company Name
    Corthera
  • Mailing Address
    1660 S. Amphlett Blvd. San Mateo, CA 94402-2525
  • Company Description
    Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera’s lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.
  • Website
    http://www.corthera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Domain Associates
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    Undisclosed

Trending on Xconomy